MannKind | MNKD - Loan Capital

Stock Price
5.63
Daily Change
0.12 2.09%
Monthly
-3.85%
Yearly
-0.09%
Q1 Forecast
5.60

MannKind reported $303.65M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Adma Biologics USD 70.08M 3.32M Sep/2025
Dynavax Technologies USD 220.97M 214K Sep/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
Halozyme Therapeutics USD 800.07M 709.03M Sep/2025
Insmed USD 539.72M 21.23M Sep/2025
MacroGenics USD 70.26M 4K Sep/2025
MannKind USD 303.65M 72.94M Sep/2025
Merck USD 39.97B 6B Sep/2025
Novo Nordisk DKK 14.02B 224.49M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Sanofi EUR 15.72B 2.45B Dec/2025
Xencor USD 87.78M 6.96M Sep/2025